These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6791943)

  • 1. Blood-brain barrier permeability of L-dopa in man.
    Friis ML; Paulson OB; Hertz MM; Bolwig TG
    Eur J Clin Invest; 1981 Jun; 11(3):231-4. PubMed ID: 6791943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of carbidopa and dimethyl sulfoxide on the permeability of the hemato-encephalic barrier for 14C-tyrosine and 14C-DOPA in rats].
    Borisenko SA
    Biull Eksp Biol Med; 1988 Dec; 106(12):686-8. PubMed ID: 3145042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of bromocriptine across the blood-brain barrier in man.
    Friis ML; Paulson OB; Hertz MM
    Acta Neurol Scand; 1979 Mar; 59(2-3):88-95. PubMed ID: 377891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Adrenergics enhance brain extraction of levodopa.
    Uc EY; Dienel GA; Cruz NF; Harik SI
    Mov Disord; 2002 Jan; 17(1):54-9. PubMed ID: 11835439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 3-OM-dopa on monoamine metabolism in rat brain.
    Gervas JJ; Muradás V; Bazán E; Aguado EG; de Yébenes JG
    Neurology; 1983 Mar; 33(3):278-82. PubMed ID: 6681870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of a single ethanol administration on the permeability of the hemato-encephalic barrier for 14C-tyrosine, 14C-DOPA and horseradish peroxidase].
    Burov IuV; Borisenko SA; Kiianmaa K; Lehtosalo J; Mannisto P
    Biull Eksp Biol Med; 1986 Mar; 101(3):331-4. PubMed ID: 3082384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cerebral metabolism of L-dihydroxyphenylalanine. An autoradiographic and biochemical study.
    Horne MK; Cheng CH; Wooten GF
    Pharmacology; 1984; 28(1):12-26. PubMed ID: 6701184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of L-dopa and carbidopa combined treatments on human catecholaminergic cells.
    Colamartino M; Padua L; Meneghini C; Leone S; Cornetta T; Testa A; Cozzi R
    DNA Cell Biol; 2012 Nov; 31(11):1572-9. PubMed ID: 23020119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative evaluation of the blood-brain barrier capacity to form dopamine from circulating L-DOPA.
    Hardebo JE; Edvinsson L; Owman C; Rosengren E
    Acta Physiol Scand; 1977 Mar; 99(3):377-84. PubMed ID: 848309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral pharmacokinetic handling and metabolism of L-dopa in the rat: the effect of route of administration and carbidopa pretreatment.
    Rose S; Jenner P; Marsden CD
    J Pharm Pharmacol; 1991 May; 43(5):325-30. PubMed ID: 1680174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.
    Kageyama T; Nakamura M; Matsuo A; Yamasaki Y; Takakura Y; Hashida M; Kanai Y; Naito M; Tsuruo T; Minato N; Shimohama S
    Brain Res; 2000 Oct; 879(1-2):115-21. PubMed ID: 11011012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-asarone and levodopa co-administration increase striatal dopamine level in 6-hydroxydopamine induced rats by modulating P-glycoprotein and tight junction proteins at the blood-brain barrier and promoting levodopa into the brain.
    Huang L; Deng M; He Y; Lu S; Ma R; Fang Y
    Clin Exp Pharmacol Physiol; 2016 Jun; 43(6):634-43. PubMed ID: 26991136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracer uptake by circumventricular organs--a relative measure of blood supply to the brain.
    Rühle HJ
    Prog Brain Res; 1992; 91():205-8. PubMed ID: 1410405
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of L-DOPA/carbidopa administration on the levels of L-DOPA, other amino acids and related compounds in the plasma, brain and heart of the rat.
    Diederich C; Milakofsky L; Hare TA; Hofford JM; Dadmarz M; Vogel WH
    Pharmacology; 1997 Sep; 55(3):109-16. PubMed ID: 9346399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of L-dopa with and without inhibition of extra cerebral dopa decarboxylase on gastric acid secretion and gastrin release in man.
    Caldara R; Barbieri C; Piepoli V; Borzio M; Masci E
    Gut; 1985 Oct; 26(10):1014-7. PubMed ID: 4054700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central cardiovascular effects of L-DOPA and clonidine in the lizard, Agama caudospinosa.
    Johansson P
    Acta Physiol Scand; 1982 Sep; 116(1):37-40. PubMed ID: 7158390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of carbidopa on the pharmacokinetics and metabolism of intravenously administered levodopa in blood plasma and skeletal muscle.
    Deleu D; Sarre S; Ebinger G; Michotte Y
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):576-81. PubMed ID: 8133901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of carbidopa and entacapone pretreatment on the L-dopa pharmacokinetics and metabolism in blood plasma and skeletal muscle in beagle dog: an in vivo microdialysis study.
    Deleu D; Sarre S; Ebinger G; Michotte Y
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1323-31. PubMed ID: 7791104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the enzymatic blood-brain barrier: quantitative measurements of DOPA decarboxylase in the wall of microvessels as related to the parenchyma in various CNS regions.
    Hardebo JE; Falck B; Owman C; Rosengren E
    Acta Physiol Scand; 1979 Apr; 105(4):453-60. PubMed ID: 452922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
    Rose S; Jenner P; Marsden CD
    Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.